RADIUS HEALTH INC. overview

TYMLOS ® demonstrated a lower incidence of hip fracture and non-vertebral fracture compared to teriparatide in women with osteoporosis 50 years and older (n=43,352) in this analysis of real-world data BOSTON, MA / ACCESSWIRE / April 16, 2024 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health, presented real-world evidence from an analysis comparing the effectiveness of TYMLOS...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Radius Health, Inc. (NasdaqGM: RDUS) to Gurnet Point Capital and Patient Square Capital. Under the terms of the proposed transaction, shareholders of Radius will receive only $10.00 per share in cash plus a CVR (Contingent Value Right) of $1.00 per share for each share of Radius that they own. KSF is seeking to determine whether this...

Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collectively one of the largest stockholders of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), with beneficial ownership of approximately 7.7% of the outstanding shares and economic exposure to approximately 10.1% of the outstanding shares, today released the following statement: “While we believe that the...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Radius Health, Inc. (“Radius” or “the Company”) (NASDAQ: RDUS ) for potential breaches of fiduciary duty on the part of its directors and management. If you are a shareholder who has held shares of Radius purchased prior to June 23, 2022 , click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Radius Health, Inc. (“Radius” or “the Company”) (NASDAQ: RDUS ) for potential breaches of fiduciary duty on the part of its directors and management. If you are a shareholder who has held shares of Radius purchased prior to June 23, 2022 , click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park...

RDUS ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Radius Health, Inc. by Gurnet Point Capital and Patient Square Capital PR Newswire NEW YORK, July 5, 2022 NEW YORK , July 5, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) stock prior to June 23, 2022 . You are hereby notified that Levi &...

Equity Alert - The M&A Class Action Firm Announces an Investigation of Radius Health, Inc. - RDUS PR Newswire NEW YORK, June 27, 2022 NEW YORK , June 27, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City , is investigating Radius...

SHAREHOLDER ALERT: Weiss Law Investigates Radius Health, Inc. PR Newswire NEW YORK, June 27, 2022 NEW YORK , June 27, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Radius Health, Inc. ("Radius Health" or the "Company") (NASDAQ: RDUS), in connection with the proposed acquisition of the Company by Gurnet Point Capital and Patient Square Capital via tender offer. Under the terms of the merger agreement,...